Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study.

Stelara (ustekinumab) - J&J

Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim

http://www.ncbi.nlm.nih.gov/pubmed/42791206

Adam Reich; Akimichi Morita; Amy S Paller; Asunción Vicente; Dolly Sharma; Doug Ashley; Irene Lara-Corrales; Kristina Unnebrink; Michael Bukhalo; Nina Magnolo; Ronilda D'Cunha; Rosie D Lyles; Toni Anschutz; Tshepiso Madihlaba; Wine Lee Lara

Sep 26, 2026